UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028389
Receipt number R000032498
Scientific Title Histological evaluation of Mucosal Defect after Cold Snare Polypectomy
Date of disclosure of the study information 2017/07/31
Last modified on 2021/12/14 17:14:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Histological evaluation of Mucosal Defect after Cold Snare Polypectomy

Acronym

cold biopsy study

Scientific Title

Histological evaluation of Mucosal Defect after Cold Snare Polypectomy

Scientific Title:Acronym

cold biopsy study

Region

Japan


Condition

Condition

colorectal polyps

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine if mucosal layer is completely resected by cold snare polypectomy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incomplete resection rate of mucosal layer by cold snare polypectomy

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

non-pedunculated colorectal polyps with a diameter of 4-9 mm

Key exclusion criteria

Inflammatory bowel disease
Polyposis
Antiplatelet or anticoaglant can not be stopped
Coagulopathy
Severe organ failure

Target sample size

221


Research contact person

Name of lead principal investigator

1st name Yoji
Middle name
Last name Takeuchi

Organization

Osaka International Cancer Institute

Division name

Department of Gastrointestinal Oncology

Zip code

5418567

Address

3-1-69, Otemae, Chuo-ku, Osaka

TEL

06-6945-1181

Email

takeuti-yo@mc.pref.osaka.jp


Public contact

Name of contact person

1st name Satoki
Middle name
Last name Shichijo

Organization

Osaka International Cancer Institute

Division name

Department of Gastrointestinal Oncology

Zip code

5418567

Address

3-1-69, Otemae, Chuo-ku, Osaka

TEL

06-6945-1181

Homepage URL


Email

7satoki@oici.jp


Sponsor or person

Institute

Osaka International Cancer Institute

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka International Cancer Institute

Address

3-1-69, Otemae, Chuo-ku, Osaka

Tel

06-6945-1181

Email

rinri01@opho.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 07 Month 31 Day


Related information

URL releasing protocol

https://onlinelibrary.wiley.com/doi/abs/10.1111/jgh.14824

Publication of results

Published


Result

URL related to results and publications

https://onlinelibrary.wiley.com/doi/abs/10.1111/jgh.14824

Number of participants that the trial has enrolled

188

Results

From August 2017 to October 2018, 188 patients were screened, and 357 polyps were included. CSDP was detected in 122/355 (34%) evaluated mucosal defects. Excluding five lesions requiring hemostasis immediately following CSP, 352 mucosal defects were biopsied. After excluding 102 biopsies containing normal mucosa, we evaluated 250 biopsies. The overall incidence of incomplete mucosal layer resection was 63% (159/250), 76% (68/90) with CSDP and 57% (91/159) without CSDP (P < 0.01).

Results date posted

2020 Year 01 Month 27 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

From August 2017
to October 2018, 188 patients participated, and 357 polyps in 177 patients were resected by CSP.

Participant flow

We recruited patients who were scheduled to undergo colorectal polypectomy, and written informed consent was obtained for participation in this study. The exclusion criteria were inflammatory bowel disease, familial polyposis, antiplatelet drugs or anticoagulants that could not be discontinued according to the Japanese guidelines,10 abnormal coagulopathy, severe organ failure, and patients who were judged unsuitable by their primary doctors.

Adverse events

Postprocedural bleeding occurred in three patients and was managed endoscopically without blood transfusion. One bleeding incident originated from a study lesion, and the other two bleeding incidences followed endoscopic mucosal resection with electrocautery for polyps measuring 10 and 20 mm, respectively. No perforation or other adverse eventswere observed.

Outcome measures

The primary outcome was the incidence of incomplete mucosal layer resection (presence of muscularis mucosa or residual polyp in the biopsied specimen).
Secondary outcomes were the incidence of CSDP, residual polyp in biopsied specimens, and any adverse event.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2017 Year 06 Month 19 Day

Date of IRB

2017 Year 07 Month 12 Day

Anticipated trial start date

2017 Year 07 Month 31 Day

Last follow-up date

2018 Year 11 Month 18 Day

Date of closure to data entry

2018 Year 11 Month 18 Day

Date trial data considered complete

2018 Year 11 Month 18 Day

Date analysis concluded

2018 Year 11 Month 27 Day


Other

Other related information

The aim is to examine the rate of complete resection of mucosal layer.


Management information

Registered date

2017 Year 07 Month 26 Day

Last modified on

2021 Year 12 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032498


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name